Argo CK - Search Results

1

Hepatitis C disease severity in living versus deceased donor liver transplant recipients: an extended observation study.

Terrault NA, Stravitz RT, Lok AS, Everson GT, Brown RS Jr, Kulik LM, Olthoff KM, Saab S, Adeyi O, Argo CK, Everhart JE, Rodrigo del R; A2ALL Study Group. Terrault NA, et al. Among authors: argo ck. Hepatology. 2014 Apr;59(4):1311-9. doi: 10.1002/hep.26920. Epub 2014 Mar 1. Hepatology. 2014. PMID: 24677192 Free PMC article.

2

Excess mortality on the liver transplant waiting list: unintended policy consequences and Model for End-Stage Liver Disease (MELD) inflation.

Northup PG, Intagliata NM, Shah NL, Pelletier SJ, Berg CL, Argo CK. Northup PG, et al. Among authors: argo ck. Hepatology. 2015 Jan;61(1):285-91. doi: 10.1002/hep.27283. Epub 2014 Oct 29. Hepatology. 2015. PMID: 24995689

3

Donor factors predicting recipient survival after liver retransplantation: the retransplant donor risk index.

Northup PG, Pruett TL, Kashmer DM, Argo CK, Berg CL, Schmitt TM. Northup PG, et al. Among authors: argo ck. Am J Transplant. 2007 Aug;7(8):1984-8. doi: 10.1111/j.1600-6143.2007.01887.x. Am J Transplant. 2007. PMID: 17617863 Free article.

4

Liver allografts from hepatitis C positive donors can offer good outcomes in hepatitis C positive recipients: a US National Transplant Registry analysis.

Northup PG, Argo CK, Nguyen DT, McBride MA, Kumer SC, Schmitt TM, Pruett TL. Northup PG, et al. Among authors: argo ck. Transpl Int. 2010 Oct;23(10):1038-44. doi: 10.1111/j.1432-2277.2010.01092.x. Transpl Int. 2010. PMID: 20444239 Free article.

5

Combined liver-kidney and liver transplantation in patients with renal failure outcomes in the MELD era.

Schmitt TM, Kumer SC, Al-Osaimi A, Shah N, Argo CK, Berg C, Pruett TL, Northup PG. Schmitt TM, et al. Among authors: argo ck. Transpl Int. 2009 Sep;22(9):876-83. doi: 10.1111/j.1432-2277.2009.00887.x. Epub 2009 Apr 27. Transpl Int. 2009. PMID: 19413580 Free article.

6

Advanced recipient age (>60 years) alone should not be a contraindication to liver retransplantation.

Schmitt TM, Kumer SC, Pruett TL, Argo CK, Northup PG. Schmitt TM, et al. Among authors: argo ck. Transpl Int. 2009 Jun;22(6):601-5. doi: 10.1111/j.1432-2277.2009.00845.x. Epub 2009 Feb 10. Transpl Int. 2009. PMID: 19220825 Free article.

7

Pretransplant predictors of recovery of renal function after liver transplantation.

Northup PG, Argo CK, Bakhru MR, Schmitt TM, Berg CL, Rosner MH. Northup PG, et al. Among authors: argo ck. Liver Transpl. 2010 Apr;16(4):440-6. doi: 10.1002/lt.22008. Liver Transpl. 2010. PMID: 20205164 Free article.

8

NASH and cryptogenic cirrhosis: a histological analysis.

Caldwell SH, Lee VD, Kleiner DE, Al-Osaimi AM, Argo CK, Northup PG, Berg CL. Caldwell SH, et al. Among authors: argo ck. Ann Hepatol. 2009 Oct-Dec;8(4):346-52. Ann Hepatol. 2009. PMID: 20009134 Free PMC article.

9

Regional variability in symptom-based MELD exceptions: a response to organ shortage?

Argo CK, Stukenborg GJ, Schmitt TM, Kumer SC, Berg CL, Northup PG. Argo CK, et al. Am J Transplant. 2011 Nov;11(11):2353-61. doi: 10.1111/j.1600-6143.2011.03738.x. Am J Transplant. 2011. PMID: 22029544 Free article.

10

Safety profile of boceprevir and telaprevir in chronic hepatitis C: real world experience from HCV-TARGET.

Gordon SC, Muir AJ, Lim JK, Pearlman B, Argo CK, Ramani A, Maliakkal B, Alam I, Stewart TG, Vainorius M, Peter J, Nelson DR, Fried MW, Reddy KR; HCV-TARGET study group. Gordon SC, et al. Among authors: argo ck. J Hepatol. 2015 Feb;62(2):286-93. doi: 10.1016/j.jhep.2014.08.052. Epub 2014 Sep 10. J Hepatol. 2015. PMID: 25218788 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82 results

Search Page